Generex Biotechnology Corporation, founded in 1983 and headquartered in Miramar, Florida, was involved in diverse areas within the biotechnology and medical device industries. Initially, the company concentrated on developing and administering large molecule pharmaceutical formulations to the oral cavity using a specialized hand-held aerosol applicator across Canada and the United States. A prominent product from this initiative was Generex Oral-lyn, an oral insulin.